BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Pharmacogenetics
,
Lipopolysaccharide
,
rs2230926
,
NEUROG3
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mice, congenic
Summary
General Info
Curated Studies
Most Correlated Studies
Livers from mice fed androstenedione, ethinyl estradiol, or prednisone
Liver tissue from gonadal hormone treated mice versus pool
Uterus of COUP-TFII mutant mice treated with oil or ICI 182,780
Breast cancer ZR-75-1 cells xenografts of mice treated with E2, enobosarm and DHT
Breast cancer GAR13-15 and HC1-005 xenografts from NSG mice treated with DHT or enobosarm
Explore Curated Studies Results
Literature
Most Relevant Literature
Diabetic modifier QTL, Dbm4, affecting elevated fasting blood glucose concentrations in congenic mic…
Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin.
A caveat for T cell transfer studies: generation of cytotoxic anti-Thy1.2 antibodies in Thy1.1 conge…
IL-2 production by dendritic cells promotes Foxp3(+) regulatory T-cell expansion in autoimmune-resis…
Different sensitivity in expression of transcription factor mRNAs in congenic mice following exposur…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ